Intensive Care for Complications of Malignant Disease: Presentation and Outcome
In recent years there have been many important advances in the management of malignant disease and as a result cancer is no longer inevitably fatal. Although there have been some significant developments in the management of solid tumors, the most dramatic improvements in long term outcome have been seen in patients with hematological and lymphoreticular malignancies, a significant proportion of whom can now be cured with aggressive chemotherapy [1, 2]. There have also been important improvements in supportive care; in particular the administration of platelet concentrates has reduced the incidence of fatal thrombocytopenic hemorrhage and the development of specialist nursing techniques, combined with the more effective use of anti-microbial agents has greatly reduced the mortality from intercurrent infection.
KeywordsLymphoma Dopamine Corticosteroid Pneumonia Oncol
Unable to display preview. Download preview PDF.
- 2.Bassan R, Rohatiner AZS, Gregory W, Amess J, Binils R, Barnett MJ, Lister TA (1987) The treatment of acute myelogenous leukaemia. Haematol Blood Transf 31:35–36Google Scholar
- 7.Bodey GP, Bolivar R, Fainstein AV (1982) Infectious complications in leukemic patients. Sem Hematol 19:193–226Google Scholar
- 9.Anger B, Schmeiser T, Sigel H, Heimpel H (1987) Intensive care therapy for patients with hematological diseases. Haematol Bluttransfus 30:519–523Google Scholar
- 18.Goldiner PL, Pinilla J, Turnbull A (1976) Acute respiratory failure in patients with advanced lymphoma. In: Lacker MJ (ed) Hodgkins disease. Wiley & Sons, New York, pp 371–376Google Scholar
- 34.Hinds CJ, Watson JD (1985) Intensive care. In: Shepherd JH, Monaghan JH (eds) Clinical gynaecological oncology. Blackwell Scientific Publications, Oxford, pp 351–368Google Scholar
- 41.Lister TA, Rohatiner AZS (1982) The treatment of acute myelogenous leukaemia in adults. Sem Hemat 19:172–191Google Scholar